ACLX
Price
$65.35
Change
+$0.58 (+0.90%)
Updated
Jun 27 closing price
Capitalization
3.6B
49 days until earnings call
MLYS
Price
$13.71
Change
-$0.29 (-2.07%)
Updated
Jun 27 closing price
Capitalization
893.55M
42 days until earnings call
Interact to see
Advertisement

ACLX vs MLYS

Header iconACLX vs MLYS Comparison
Open Charts ACLX vs MLYSBanner chart's image
Arcellx
Price$65.35
Change+$0.58 (+0.90%)
Volume$1.7M
Capitalization3.6B
Mineralys Therapeutics
Price$13.71
Change-$0.29 (-2.07%)
Volume$2.23M
Capitalization893.55M
ACLX vs MLYS Comparison Chart in %
Loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACLX vs. MLYS commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACLX is a Buy and MLYS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (ACLX: $65.35 vs. MLYS: $13.71)
Brand notoriety: ACLX and MLYS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACLX: 224% vs. MLYS: 268%
Market capitalization -- ACLX: $3.6B vs. MLYS: $893.55M
ACLX [@Biotechnology] is valued at $3.6B. MLYS’s [@Biotechnology] market capitalization is $893.55M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACLX’s FA Score shows that 0 FA rating(s) are green whileMLYS’s FA Score has 0 green FA rating(s).

  • ACLX’s FA Score: 0 green, 5 red.
  • MLYS’s FA Score: 0 green, 5 red.
According to our system of comparison, MLYS is a better buy in the long-term than ACLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACLX’s TA Score shows that 4 TA indicator(s) are bullish while MLYS’s TA Score has 3 bullish TA indicator(s).

  • ACLX’s TA Score: 4 bullish, 3 bearish.
  • MLYS’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ACLX is a better buy in the short-term than MLYS.

Price Growth

ACLX (@Biotechnology) experienced а +3.73% price change this week, while MLYS (@Biotechnology) price change was +1.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

ACLX is expected to report earnings on Aug 18, 2025.

MLYS is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACLX($3.6B) has a higher market cap than MLYS($894M). MLYS YTD gains are higher at: 11.373 vs. ACLX (-14.787). ACLX has higher annual earnings (EBITDA): -153.96M vs. MLYS (-201.44M). ACLX has more cash in the bank: 543M vs. MLYS (343M). ACLX has higher revenues than MLYS: ACLX (76.8M) vs MLYS (0).
ACLXMLYSACLX / MLYS
Capitalization3.6B894M403%
EBITDA-153.96M-201.44M76%
Gain YTD-14.78711.373-130%
P/E RatioN/AN/A-
Revenue76.8M0-
Total Cash543M343M158%
Total Debt53.2MN/A-
TECHNICAL ANALYSIS
Technical Analysis
ACLXMLYS
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
63%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
84%
Momentum
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 4 days ago
89%
MACD
ODDS (%)
Bearish Trend 4 days ago
77%
Bearish Trend 4 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
89%
Bullish Trend 4 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
88%
Bearish Trend 4 days ago
84%
Advances
ODDS (%)
Bullish Trend 4 days ago
87%
N/A
Declines
ODDS (%)
Bearish Trend 14 days ago
79%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
N/A
Bullish Trend 4 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 4 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VWUSX77.030.61
+0.80%
Vanguard US Growth Investor
MLVAX19.170.07
+0.37%
MFS Low Volatility Equity A
EVIFX12.310.03
+0.24%
Eaton Vance Balanced A
EGWRX18.000.04
+0.22%
Allspring Discovery Small Cap Gr R6
FBFQX12.550.01
+0.08%
Franklin Managed Income R

ACLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACLX has been loosely correlated with CGON. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ACLX jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACLX
1D Price
Change %
ACLX100%
+0.90%
CGON - ACLX
56%
Loosely correlated
-0.46%
RNA - ACLX
56%
Loosely correlated
-2.68%
KRYS - ACLX
54%
Loosely correlated
-2.60%
DNLI - ACLX
54%
Loosely correlated
-2.69%
BEAM - ACLX
53%
Loosely correlated
-1.98%
More

MLYS and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLYS has been loosely correlated with PTGX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if MLYS jumps, then PTGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLYS
1D Price
Change %
MLYS100%
-2.07%
PTGX - MLYS
51%
Loosely correlated
+0.86%
BIESF - MLYS
45%
Loosely correlated
N/A
XERS - MLYS
37%
Loosely correlated
-0.84%
CRNX - MLYS
36%
Loosely correlated
-0.10%
ACLX - MLYS
36%
Loosely correlated
+0.90%
More